I will be out of the office starting 09/08/2005 and will not return until 09/12/2005.

I will reply to your message upon my return.

Another issue is whether or not there will be a call in number or if people
will be contacted from one location.   Betsi is in South Africa.   Will
there be capability for folks outside of N. America to participate on the
call?   I will be unable to do any organizing for this call after Monday
September 12 due to travel.  Can folks submit agenda items and names of
people available and willing to participate on the call?    Beri

-----Original Message-----
From: -leah- [mailto:leah@...]
Sent: Thursday, September 08, 2005 11:09 AM
To: Thomson, Kate; Betsi Pendry; aidsinitiative@yahoogroups.com
Cc: louise.binder@...; Aidsinitiative; Promise Mthembu;
graciavioleta@...; Beri Hull; kimt@...
Subject: RE: [aidsinitiative] RE: International/Blueprint call etc.

Hi Kate,

I just want to clarify your suggestions.

1. The dinner remain on October 21.

2. The call be on Sept. 16.  The original time was noon, but we were
looking into peoples' availability for 1:30 EST, due to Betsi's
inability to join.  I have sent off an email to the Canadian members
asking about their availability at 1:30.  Please clarify which time
is preferred.

Thanks,
Leah

At 3:58 PM +0200 9/8/05, Thomson, Kate wrote:
>Dear All,
>
>Apologies for the confusion.  I was not aware that plans had already
>been made when I suggested the dinner.  I suggest you keep the original
>dates for the dinner and the conference call.  In addition, Promise,
>Violeta and myself will be very happy to meet for dinner or a drink with
>any of you who are in Toronto on the 15 or 16 September. Please let me
>know if this works for you.
>
>Thanks,
>
>Kate
>
>-----Original Message-----
>From: Betsi Pendry [mailto:bitpendry@...]
>Sent: Thursday, 08 September, 2005 00:34
>To: aidsinitiative@yahoogroups.com; -leah-
>Cc: Thomson, Kate; louise.binder@...; Aidsinitiative
>Subject: Re: [aidsinitiative] RE: International/Blueprint call etc.
>
>
>Dear All, I thought the call for us all was later, the next week, not
>the 16th, I cannot do the 16th unless it is later, as I have a
>committment until 7:30 PM, ( 1:30 NYC time...is it possible to change
>the timing ? could it be at 1:30 EST ? if so, then I can be on it. Sorry
>of I misunderstood the dates and times, but I thought it was the
>following week, on the 22 or so... Betsi
>
>
>----- Original Message -----
>From: "Beri Hull" <beri@...>
>To: "-leah-" <leah@...>
>Cc: "Kate Thomson" <thomsonk@...>; <louise.binder@...>;
>"Aidsinitiative" <aidsinitiative@yahoogroups.com>
>Sent: Wednesday, September 07, 2005 10:59 PM
>Subject: [aidsinitiative] RE: International/Blueprint call etc.
>
>
>>  Dear Leah,
>>
>>  The dinner meeting in Toronto will be moved from the 21 to the 15 or
>>  the
>16,
>>  Kate Thompson is helping to coordinate that change.
>>
>>   I will cc the entire Bill of Barcelona group regarding the call on
>>  the
>16th
>>  at noon EST.  It may be a situation of first comes first serve.  There
>
>>  may be more than five that want to participate.  Do you know if this
>>  is the
>type
>>  of call where you should provide a number where you can be reached or
>>  will there be a toll free number?
>>
>>  Beri
>>
>>  -----Original Message-----
>>  From: -leah- [mailto:leah@...]
>>  Sent: Wednesday, September 07, 2005 3:46 PM
>>  To: beri@...
>>  Cc: louise.binder@...
>>  Subject: International/Blueprint call etc.
>>
>>  Hi Beri,
>>
>>  I received a message from Louise confirming Sept. 16 @ noon for the
>>  call between the International group and the Blueprint.  I have sent
>>  an email to Kim Thomas asking her to organize 5 or 6 people to join. I
>
>>  understand that you are preparing a list of 5 or 6 people to join the
>>  call as well.
>>
>>  I also understand that you are organizing a dinner on October 21 for a
>
>>  meeting between Blueprint members and the Programme Planning
>>  Committee.   If I can be of any assistance, please let me know.
>>  Also, please copy me on those emails so I'm up to date on logistics
>>  (time, place etc.)  I will send a heads up email to the Toronto-based
>>  Blueprint members.
>>
>>  Finally, Louise asked me to apologize to you.  She was at the airport
>>  when she accidentally hung up on you and she didn't have your number
>>  on hand to call you back.  Again, her sincere apologies.
>>
>>  Thanks, Beri,
>>
>>  Leah
>>
>>
>>
>>  ------------------------ Yahoo! Groups Sponsor
>>  --------------------~--> Affected by disease? Support health awareness
>
>>  efforts at Network for Good.
>>  http://us.click.yahoo.com/qnM_qD/cnQLAA/xGEGAA/07SolB/TM
>  >
>--------------------------------------------------------------------~->
>>
>>
>>  Yahoo! Groups Links
>>
>>
>>
>>
>>
>>

I will be out of the office starting 08/26/2005 and will not return until 08/29/2005.

I will reply to your message upon my return.

The Female Health Foundation News - Issue 2, July 2005

Welcome to the quarterly Female Health Foundation News! The Female Health Foundation, the not for profit arm of The Female Health Company, works with key stakeholders in individual countries to implement HIV/STD prevention/family planning/workplace programmes with an FC female condom component. This newsletter will disseminate information on these programmes as well as best practice materials, published research and impact data from around the world.

To subscribe to the newsletter please send an e-mail to info@...   with the subject line SUBSCRIBE

In this issue:

China - Female Condom Consultation Meeting- April 2005
International Council of Nurses Congress, Taipei, 22 May 2005
FHF's Intervention Toolkit
Research - Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions
A.M.Minnis, N.S.Padian Sexually Transmitted Infections January 2005; 81: 193 - 200

China - Female Condom Consultation Meeting, April 2005

A consultation took place in China in April 2005 to discuss ways of making the female condom available to all women in the country. The meeting was attended by 48 participants representing national government, provincial governments, international and local NGOs, UN organisations, businesses and representatives from the private sector. Ms Guo Wei of the UNFPA/WHO 100% condom use project, which has concentrated on promoting condom use in nine provinces in China, believes that female condoms must have political support as well as widespread education programmes and outreach and mass media campaigns to reach high risk groups and the general population.

The Futures Group presented findings from their research intervention in Yunnan and Sichuan on acceptability of female condoms among female sex workers. Key findings of the research were; a general acceptability rate for the female condom of 70%; that protected sexual acts increased by 10% during the period of the study; and that users found the female condom equivalent to the male condom in terms of sexual pleasure and comfort. Importantly the study indicated that practical difficulties associated with female condom insertion were resolved over time.

Population Services International has been promoting the female condom to high risk women, including sex workers, in Honghe, Yunnan and Ruili. Nanjing College and Columbia University, USA, are researching acceptability of FC among couples in Kunshan County, Jiangsu province using a research model developed by the Reproductive Health Research Unit in South Africa. Findings from this study may be used to promote FC to the general population.

For more information please contact:
The Futures Group at futures1@...
Population Services International at ghafner@...

International Council of Nurses Congress, Taipei, 22 May 2005

Celebrating nursing innovation and knowledge, more than 3500 nurses from 131 countries and every region of the world gathered in Taipei, Taiwan to participate in the International Council of Nurses (ICN) 23rd Quadrennial Congress 21-27 May 2005. The scientific programme boasted more than 1500 presentations, including main sessions, symposia, workshops, special interest sessions and posters. Topics included how nurses can help overcome barriers to access to female condoms--both as providers and advocates.

The Female Health Foundation presented on " Access to Female-Initiated Prevention" focusing on a rights based approach to choices for protection, the role of nursing in advancing access to female condoms and mobilizing political action for female-initiated prevention. Copies of the presentation are available from pweisenfeld@...

Effectiveness of female controlled barrier methods in preventing sexually transmitted infections and HIV: current evidence and future research directions
A.M.Minnis, N.S.Padian Sexually Transmitted Infections January 2005; 81: 193 - 200

The review aimed to evaluate evidence for the effectiveness of female controlled physical and chemical barrier methods in preventing STI/HIV transmission as well as translating results into public health interventions. Information about various female controlled methods was presented including diaphragms, cervical caps, microbicides and the FC female condom. The authors reviewed three studies which looked at the disease prevention effectiveness of the FC female condom. The authors state that the studies "suggest that the availability and use of the [FC] female condom offers at least as much protection from STIs as male condoms alone".

The authors concluded that female controlled barrier methods are an essential tool to prevent the continued spread of STI/HIV infections. Additionally they provide women with the opportunity to take an active role in reducing their STI/HIV risk.

FHF's Intervention Toolkit

Based on its experience in the field, FHF has created an intervention toolkit which is designed to help public health specialists and programme managers improve the assessment, planning, design, implementation and monitoring and evaluation of female condom interventions. It guides users through a process to gather, synthesise and analyse information to support and define female condom programme objectives and interventions.

There is also a collection of tools to assist in this process, amongst others; an introductory pack containing a flipchart, briefing card and case studies; a manual for cascade leader and motivator training; and examples of work plans and log frames to assist with the strategic planning phase. Additionally it includes practical advice for programme managers introducing female condom programmes for the first time as well as for those intending to revise/re-evaluate and update existing programmes.

FHF is keen to receive feedback from those organisations working on or intending to implement female condom interventions to ensure that the toolkit is practical, user friendly and covers the key aspects of female condom programming. We would be happy to supply you with a trial kit for your use and feedback. A feedback form will be attached for each section. FHF is planning to complete the prototype of the kit by the end of July. If you would like to participate in reviewing the tool kit, please send an e-mail to ebayliss@...

We welcome your input and contributions for future issues!
Correspondence can be addressed to info@...
Further information on FC female condom is available at www.femalehealth.com
Visit http://www.femalehealth.com/resources.html#newsletter for previous editions

 
Dear all,
 
Please find herewith the last issue of AIDS 2006 newsletter highlighting the most important features of the XVI International AIDS Conference to be held in Toronto, Canada, 13-18 August 2006.
 
For more information, check www.aids2006.org for regular updates or contact AIDS 2006 Conference Secretariats.
 
Sincerely,
AIDS 2006 Secretariat

International AIDS Society HQ

33 Chemin de L'Avenchet
CH - 1216 Cointrin
Geneva, Switzerland
Tel: +41 22 710 0800
Fax: +41 22 710 0899
www.aids2006.org
 
 
 

I will be out of the office starting 07/29/2005 and will not return until 08/29/2005.

Je réponderai à mon retour. Pour toute urgence, contactez Kim Thomas au kimt@...
I will respond to your message when I return. For urgent matters, contact Kim Thomas at kimt@...

En cas d'urgence, contactez Kim Thomas, Directrice des programmes au kimt@...

For urgent matters, contact Kim Thomas, Director of Programs at kimt@...
En cas d'urgence, contactez Paul Lapierre au paull@..., (613) 230-3580, poste 118.

For urgent matters, contact Paul Lapierre at paull@..., (613) 230-3580, ext.118

I will be out of the office starting 07/29/2005 and will not return until 08/17/2005.

I will reply to your message upon my return.

Attached and pasted below, please find the current issue of HHS Watch.

This month’s issue has a special focus on groundbreaking recent studies and analysis of research methods assessing condom efficacy. The Bush Administration and allies have been distributing misleading information casting doubts on the effectiveness of condoms. Senator Coburn is pushing for warning labels on condoms, bolstered by congressional legislation mandating FDA review of condom labeling.

Proponents of abstinence-only are fond of talking about HPV, claiming that it can not be prevented by condom use. Past data showed that, in fact, condom usage reduces the harmful consequences of HPV, including cervical cancer. New data, summarized below, shows that appropriate research methods reveal that condom use does in fact reduce HPV infection itself.

We hope this issue will provide useful in countering the war on condoms, and provide useful information for HIV and STD prevention.



Julie Davids
Executive Director, Community HIV/AIDS Mobilization Project (CHAMP)

594 Broadway
Suite 700
New York, NY 10012

(212) 966-0466 x 1206
(646) 431-7525 mobile

Join the CHAMP alert list: http://www.champnetwork.org/index.php?name=intakeform

Register for the Campaign to End AIDS:
www.C2EA.org

This month, the full Senate finally approved the nomination of Lester Crawford for commissioner of the Food and Drug Commission by a 76-16 vote. One of the reasons for the Crawford holdup was that Sen. Tom Coburn (R-OK) had blocked the vote, demanding FDA action on a four-year-old Congressional mandate to revise condom labels. The mandate requires the labels to include scientifically sound information about protection against specific STDs, or lack thereof. Under a compromise announced on July 15, Coburn lifted his objection to the vote on Crawford in return for a promise that the FDA will now actively pursue the condom label issue.

The re-emergence of the condom labeling issue comes at a time when scientific studies increasingly show that condoms offer more protection against STDs than previously demonstrated.

One of the most contentious of these diseases is the most common, human papillomavirus (HPV). Some HPV varieties cause genital warts and a few are the source of cervical and anal cancers (see the June HHSWatch). Although there has been some evidence that condoms reduce the rate of cervical cancer, Coburn (who is an obstetrician) and other condom critics want a specific warning on condom labels stating they cannot prevent HPV. Their reasoning is that HPV can spread by skin-to-skin contact outside the genital parts covered by condoms.


HPV: Very Common… Hard to Study… But New Research Reveals Condom Have Protective Role

HPV studies have been notoriously difficult  to do. “Previous studies had trouble because it is hard to find women who have not been infected by some HPV strain already, and they didn’t start out looking specifically at condom use in any case,â€� says Laura Koutsky, an epidemiologist and HPV expert
at the University of Washington.

To perform a rigorous evaluation, Koutsky and her colleagues followed 200 female college students who had their first sexual intercourse either during the study period or at most three months before. The women had to complete diaries about their condom use during a two-year observation period. They also underwent regular HPV testing. When the incidents of HPV infection were tallied, it turned out that the study participants who reported always using condoms during sex had 70% less risk of acquiring HPV than those who never or almost never used condoms.

The University of Washington study was presented at a July 10-13 conference sponsored by the International Society for Sexually Transmitted Diseases Research.

A University of California San Francisco study at the same conference looked at anal HPV in gay men. It found that consistent condom users’ risk of infection was 9.5 times lower than nonusers’. “It’s all about risk. If the only exposed area is a small patch outside the anal canal, then your risk of infection and significant disease is much less,� commented Peter Chin-Hong, the lead investigator.


Finding the right population

Design problems have troubled nearly all of the previous condom studies, says Lee Warner, an epidemiologist at the Centers for Disease Control and Prevention (CDC). Warner recently published two studies on chlamydia and gonorrhea, showing how poor methodology can greatly reduce estimates of condom effectiveness.

“Gonorrhea and chlamydia are two STIs where condom effectiveness should be high since these infections are all transmitted via the male urethra. They should be prevented with consistent and correct condom use, like HIV,� said Warner.

Yet here too, past results have been inconsistent. Warner and his colleagues first looked at a large cohort of women, some of whom contracted one of these diseases and some of whom did not. When the researchers compared the women’s condom use records, they could find no significant protection from consistent use. The big problem was that most of the women did not have infected partners. These were the women who tended to use condoms less regularly. Their condom non-use made no difference; they were never exposed to disease. The women more likely to have infected or suspect partners may be more careful about using condoms. They may also be more frequently exposed to gonorrhea and chlamydia on the relatively few occasions when they don’t use condoms.

To minimize this effect, Warner looked at a group of women who had partners known to be infected. Here, the results indicated a high degree of protection for consistent condom use.

Moreover, women with infected partners who reported more than ten unprotected sex acts in the previous three months had nearly four times the risk of contracting gonorrhea or chlamydia than those who reported no unprotected sex in this period. The second study evaluated condom use and infection monthly among women who contracted gonorrhea or chlamydia during a six-month observation period. Among these women, non-use of condoms in the month before infection had an effect similar to the first study. Ten or more unprotected incidents of sexual intercourse correlated with a 2.6-fold increase in risk compared to no unprotected incidents.


Prior Studies’ Methods Likely to Have Underestimated Condom Protection Rates

Both of these studies showed a very strong “dose response�: The more unprotected sex with a partner likely to be infected, the greater your chance of getting infected.

This observation underscores a subtle feature of Warner’s research. Measuring condom use in percent of sex acts does not reveal how much exposure there actually was. An individual might have sex ten times or 100 times. A 10% rate of unprotected sex in the latter case will lead to ten times the exposure to infection that it would in the former case, if the partners are infected.

The fact that these two differently constructed studies led to similar results further supports the notion that prior studies have underestimated condoms’ protection against chlamydia and gonorrhea. Warner says, “The point we were making was that conventional studies were biased to finding no effect for condoms. They were underestimating the condoms’ effectiveness. When you see consistency with different methodologies, you have more confidence in the strength of your conclusions.�


Need for correct use underscores role of education

Another major issue is poor condom technique, which obviously can make a big difference in condom results. Warner notes, “Several studies have reported large misuse of condoms, but few have related it to STDs.� In his second study, Warner’s group did take account of occurrences when condoms either slipped off or ruptured. Not surprisingly, even consistent condom users had increased odds of contracting gonorrhea or chlamydia if they reported at least one slippage or breakage incident during a given study month. Their risk was about the same as the women who reported inconsistent condom use. Still, about a third of new chlamydia and gonorrhea infections in the second study occurred during months when participants claimed that they had used condoms for all sex in the past month without slippage or breakage. Aside from false reports – which would reduce apparent condom effectiveness – this observation suggests that there are many other problems that arise when using condoms and underscores the need for more education on correct condom usage.

A final new study, published in June, directly addressed the effects of condom misuse on acquiring chlamydia and gonorrhea. In this study, CDC researchers assessed the condom experiences of sexually active female patients at an adolescent health clinic. In addition to frequency of condom use, slippage, and breakage, the researchers tracked the following typical condom errors: starting to put a condom on upside down and then flipping it over, beginning sex without a condom, and removing the condom before finishing sex. Of the 509 young women who were interviewed, 86% said that they had used a condom at least once in the previous three months. But only 16% said that they had correctly used condoms for all vaginal intercourse. Nearly three-quarters of condom users described some problem, the most frequent being beginning sex without a condom. Breakage occurred at least once in the prior three months to almost a third of condom users.

The consistent and correct condom users had a greatly reduced risk of current infection compared with non- or irregular users – 60% less risk for chlamydia and 90% less risk for gonorrhea. As with Warner’s study, women with a record of consistent but problematic use were not significantly different from those admitting to no or intermittent condom use. These data speak to the role of education, not just on the use of condoms but the correct use of condoms, and should provoke additional inquiry into abstinence-only-until-marriage programs that train only on the harmful effects of condom misuse, rather than the methods of correct use.


A common thread, and an opportunity to re-assess claims of inconclusiveness

Taken together, these studies have a constant refrain. Accurate measure of condom effectiveness requires a careful measurement of exactly how many times you are exposed to an STD. Less than perfect condom practice with an infected partner still carries a lot of risk, but downright poor behavior with an uninfected partner has no risk at all. In 2001, the National Institutes of Health issued a report on condom effectiveness that dismissed most condom research as inconclusive (except for that relating to HIV). In the coming debate on condom labeling, the advances since then in study design should have great influence so long as the political debate does not overwhelm the scientific one.


A call for evaluation of abstinence failure rates

And to flip the debate over, what about “abstinence failure� – when people rely on abstinence for protection and then have unplanned sex without condoms? As Guttmacher Institute analyst Cynthia Dailard has argued, “By contrasting the perfect use of abstinence with the typical use of other contraceptive methods… [abstinence-only promoters] are comparing apples to oranges. From a public health perspective,
it is important both to subject abstinence to the same scientific standards that apply to other contraceptive methods and to make consistent comparisons across methods.�


David Gilden researched and wrote this issue.

Sources

Winer L, Hughes JP, Feng Q, O'Reilly, Kiviat NB, Koutsky LA. The effect of consistent condom use on the risk of genital HPV infection among newly sexually active young women. 16th Biennial Meeting of the International Society for Sexually Transmitted Disease Research (ISSTDR). Amsterdam, the Netherlands. July 10-13, 2005; Poster MP-120.

Chin-Hong PV, Vittinghoff E, Benet D, Buchbinder S, Da Costa M, Darragh T, Judson F, Koblin B, Mayer K, Palefsky JM. Condoms prevent incident anal human papillomavirus (HPV) infection in men: the EXPLORE study. 16th Biennial Meeting of the International Society for Sexually Transmitted Disease Research (ISSTDR). Amsterdam, the Netherlands. July 10-13, 2005; Oral presentation MO-301.

Warner L, Newman DR, Austin HD, Kamb ML, Douglas JM Jr, Malotte CK, Zenilman JM, Rogers J, Bolan G, Fishbein M, Kleinbaum DG, Macaluso M, Peterman TA; Project RESPECT Study Group. Condom effectiveness for reducing transmission of gonorrhea and chlamydia: the importance of assessing partner infection status. Am J Epidemiol. 2004 Feb 1;159(3):242-51.

Warner L, Macaluso M, Austin HD, Kleinbaum DK, Artz L, Fleenor ME, Brill I, Newman DR, Hook EW 3rd. Application of the case-crossover design to reduce unmeasured confounding in studies of condom effectiveness. Am J Epidemiol. 2005 Apr 15;161(8):765-73.

Paz-Bailey G, Koumans EH, Sternberg M, Pierce A, Papp J, Unger ER, Sawyer M, Black CM, Markowitz LE. The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med. 2005 Jun;159(6):536-42.

Dailard C. Understanding 'abstinence': implications for individuals, programs and policies. The Guttmacher Report. Dec 2003; 6(5):4-6.


HHSWatch, a watchdog newsletter from CHAMP, monitors and reports on activities related to HIV prevention at Health and Human Services agencies, including CDC, NIH, HRSA and SAMHSA. HHSWatch is a resource for community members, policy advocates, researchers and anyone interested in more fully understanding and tracking the committees, panels and administrators whose recommendations and decisions affect our work. HHSWatch is committed to providing an outlet for those concerned about infringements upon science-based HIV prevention and treatment, and will respect your wishes for confidentiality. If you are interested in contributing information or suggesting a story, please contact champ@....

COMMUNITY HIV/AIDS MOBILIZATION PROJECT (CHAMP)
594 Broadway, Suite 700   New York, NY 10012   tel. 212-966-0466 x.1302  
www.champnetwork.org

The fed_AIDS_pol list is the private working list of the Federal AIDS Policy Partnership. Please do not forward any of the messages on this list without the permission of the original poster.

Please circulate:
Blueprint for Action on Women and HIV/AIDS in Canada: Towards 2006
Seeking a writer/researcher

In preparation for the 2006 International AIDS Conference hosted in
Toronto, Canada, when the response of the Canadian government to
HIV/AIDS issues among all Canadian populations will be under global
scrutiny, Blueprint for Action on Women and HIV in Canada: Towards
2006 (the Coalition) will bring together individuals and
organizations addressing the needs of women living with, and affected
by, HIV/AIDS in Canada to act as a united voice on policy issues.

The Coalition will seek to advocate on these issues and influence
national, provincial and municipal governments to provide services
and funding programs aimed specifically at services for women living
with HIV/AIDS and women affected and vulnerable to HIV/AIDS.

The coalition will also seek to ensure that there is a robust agenda
of women's issues presented at the International AIDS Conference
addressing the impact of HIV/AIDS on women globally, including
opportunities to see clinical science, treatment and community
services that have impacted women living with HIV/AIDS.

Description:
Drawing from the research on priority issues for women in regards to
HIV/AIDS, which the Blueprint sub-committees have done, the
consultant will compile this research, do supplementary research on
the issues, and then consult with the steering committee in order to
draft the Blueprint's key messages, a manifesto, a report card, as
well as background material, to be launched on World AIDS Day,
December 1, 2005.

Required skills and experience:
• Excellent research, writing and oral skills
• Knowledge of issues related to HIV/AIDS and gender inequity
• Excellent analysis and synthesis skills
• Bilingual
• Self-directed research ability
• Ability to work with committees
• Media and/or public relations experience

The selected candidate will work as a consultant for the Blueprint.
Exact number of days required to complete the drafts of the materials
will be confirmed, based on funding.

Women living with HIV/AIDS are encouraged to present their
candidacies. Where there are equally qualified applicants, preference
will be given to women living with HIV/AIDS. We thank all applicants,
however only those selected for interviews will be contacted.

Please send covering letter and resume by July 29th, 2005,  by fax or
email to:
Elana Wright, Canadian HIV/AIDS Legal Network
Tel.: (514) 397-6828, ext. 259
Fax: (514) 397-8507
Email: ewright@...

I will be out of the office starting 06/30/2005 and will not return until 08/02/2005.

I will respond to your message upon my return.

If you are contacting me regarding Blueprint for Action on Women and HIV/AIDS in Canada, please forward your message to Claire Checkland (clairec@...).

For other urgent matters please contact Paul Lapierre, Executive Director at paull@... or at (613) 230-3580, extension 118.